1. Epizyme Appoints Oncology Industry Leader Michael Giordano, MD, to its Board of Directors

    Epizyme Appoints Oncology Industry Leader Michael Giordano, MD, to its Board of Directors

    CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the appointment of Michael Giordano, M.D., to the company's board of directors . Dr. Giordano brings to the ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Michael is a highly respected oncology leader, bringing us a wealth of experience developing novel and highly successful cancer therapies.
    2. In working alongside the Epizyme team, I have been impressed by their passion and commitment to bringing new medicines to patients in need.
  3. Topics Mentioned